Boehringer Ingelheim Competitors and Similar CompaniesClear all

Boehringer Ingelheim's competitors and similar companies include Lilly.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
Lilly
Lilly
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
1958
Founding Date
1876
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Ingelheim am Rhein, DE HQ
Ouled Fayet, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Minsk, BY
Bruxelles, BE
see more
Locations
Indianapolis, US HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
see more
Employees
Employees
1,2338% increase
Employees
47,0009% increase

Financial

Revenue (est.)
Revenue (est.)
€12.7b (FY, 2023)
Revenue (est.)
$65.2b (FY, 2025)
Cost of goods
Cost of goods
€4b (FY, 2023)
Cost of goods
$11.1b (FY, 2025)
Gross profit
Gross profit
€8.7b (FY, 2023)
Gross profit
$54.1b (FY, 2025)
Net income
Net income
€5.8b (FY, 2023)
Net income
$20.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Lilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase

Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.

View company